 |
Journal articles
A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability.
Junwon Kim
1
Taedong Ok
1
Changmin Park
1
Wonyoung So
1
Mina Jo
1
Youngmi Kim
1
Minjung Seo
1
Doohyun Lee
1
Suyeon Jo
1
Yoonae Ko
1
Inhee Choi
1
Youngsam Park
1
Jaewan Yoon
1
Moon Kyeong Ju
1
Jiye Ahn
1
Junghwan Kim
1
Sung-Jun Han
1
Tae-Hee Kim
1, 2
Jonathan Cechetto
1
Jiyoun Nam
1
Michel Liuzzi
1
Peter Sommer
1
Zaesung No
1, *
1
Institut Pasteur Korea - Institut Pasteur de Corée (39-1, Hawolgok-dong, Sungbuk-gu, Seoul 136-791 - South Korea)
- RIIP - Réseau International des Instituts Pasteur (25, rue du Dr Roux 75724 Paris Cedex 15 - France)
2
Department of Biotechnology, College of Life Science and Biotechnology (Seoul - South Korea)
- Yonsei University (South Korea)
Abstract : Following the previous SAR of a novel dihydropyrimidinone scaffold as HIV-1 replication inhibitors a detailed study directed towards optimizing the metabolic stability of the ester functional group in the dihydropyrimidinone (DHPM) scaffold is described. Replacement of the ester moiety by thiazole ring significantly improved the metabolic stability while retaining antiviral activity against HIV-1 replication. These novel and potent DHPMs with bioisosteres could serve as advanced leads for further optimization.
Document type :
Journal articles
Domain :
Complete list of metadata
https://hal-riip.archives-ouvertes.fr/pasteur-00683846
Contributor : Peter Sommer Connect in order to contact the contributor
Submitted on : Saturday, March 31, 2012 - 12:46:35 PM
Last modification on : Wednesday, September 23, 2020 - 10:44:03 AM
Contributor : Peter Sommer Connect in order to contact the contributor
Submitted on : Saturday, March 31, 2012 - 12:46:35 PM
Last modification on : Wednesday, September 23, 2020 - 10:44:03 AM
Identifiers
- HAL Id : pasteur-00683846, version 1
- DOI : 10.1016/j.bmcl.2012.01.133
- PUBMED : 22374216
Collections
Citation
Junwon Kim, Taedong Ok, Changmin Park, Wonyoung So, Mina Jo, et al.. A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability.. Bioorganic and Medicinal Chemistry Letters, Elsevier, 2012, 22 (7), pp.2522-6. ⟨10.1016/j.bmcl.2012.01.133⟩. ⟨pasteur-00683846⟩
Metrics
Les métriques sont temporairement indisponibles